PITTSBURGH, Jan. 13, 2022 /PRNewswire/ — PANTHERx Rare announces that it has been selected by Xeris Pharmaceuticals, Inc., a wholly owned subsidiary of Xeris Biopharma Holdings, Inc., as the exclusi… [read more]